Increasing Ciprofloxacin Resistance Among Prevalent Urinary Tract Bacterial Isolates in Gaza Strip, Palestine

Overview

Journal J Biomed Biotechnol

Specialty Biology

Date 2005 Sep 30

PMID 16192681

Citations 4

Authors

Zakaria El Astal

Affiliations

Soon will be listed here.

Abstract

This article presents the incidence of ciprofloxacin resistance among 480 clinical isolates obtained from patients with urinary tract infection (UTI) during January to June 2004 in Gaza Strip, Palestine. The resistance rates observed were 15.0% to ciprofloxacin, 82.5% to amoxycillin, 64.4% to cotrimoxazole, 63.1% to doxycycline, 32.5% to cephalexin, 31.9% to nalidixic acid, and 10.0% to amikacin. High resistance to ciprofloxacin was detected among Acinetobacter haemolyticus (28.6%), Staphylococcus saprophyticus (25.0%),Pseudomonas aeruginosa (20.0%), Klebsiella pneumonia (17.6%), and Escherichia coli (12.0%). Minimal inhibitory concentration (MIC) of ciprofloxacin evenly ranged from 4 to 32 mu g/mL with a mean of 25.0 mu g/mL. This study indicates emerging ciprofloxacin resistance among urinary tract infection isolates. Increasing resistance against ciprofloxacin demands coordinated monitoring of its activity and rational use of the antibiotics.

Citing Articles

Interplay of the Quality of Ciprofloxacin and Antibiotic Resistance in Developing Countries.

Sharma D, Patel R, Zaidi S, Sarker M, Lean Q, Ming L Front Pharmacol. 2017; 8:546.

PMID: 28871228 PMC: 5566961. DOI: 10.3389/fphar.2017.00546.

Susceptibility pattern of uropathogens to ciprofloxacin at the Ghana police hospital.

Afriyie D, Gyansa-Lutterodt M, Amponsah S, Asare G, Wiredu V, Wormenor E Pan Afr Med J. 2016; 22:87.

PMID: 26848334 PMC: 4732620. DOI: 10.11604/pamj.2015.22.87.6037.

Antibiotic resistance pattern of Pseudomonas aeruginosa isolated from urine samples of Urinary Tract Infections patients in Karachi, Pakistan.

Shah D, Wasim S, Abdullah F Pak J Med Sci. 2015; 31(2):341-5.

PMID: 26101487 PMC: 4476338. DOI: 10.12669/pjms.312.6839.

Increasing ciprofloxacin resistance of isolates from infected urines of a cross-section of patients in Karachi.

Abdullah F, Memon A, Bandukda M, Jamil M BMC Res Notes. 2012; 5:696.

PMID: 23268858 PMC: 3536602. DOI: 10.1186/1756-0500-5-696.

References

Kamberi M, Tsutsumi K, Kotegawa T, Kawano K, Nakamura K, Niki Y . Influences of urinary pH on ciprofloxacin pharmacokinetics in humans and antimicrobial activity in vitro versus those of sparfloxacin. Antimicrob Agents Chemother. 1999; 43(3):525-9. PMC: 89155. DOI: 10.1128/AAC.43.3.525. View

Iqbal J, Kabir M, Rahman M . Increasing ciprofloxacin resistance among prevalent urinary tract bacterial isolates in Bangladesh. Jpn J Med Sci Biol. 1998; 50(6):241-50. DOI: 10.7883/yoken1952.50.241. View

Abu Shaqra Q . Occurrence and antibiotic sensitivity of Enterobacteriaceae isolated from a group of Jordanian patients with community acquired urinary tract infections. Cytobios. 2000; 101(396):15-21. View

King D, Malone R, Lilley S . New classification and update on the quinolone antibiotics. Am Fam Physician. 2000; 61(9):2741-8. View

Farooqi B, Shareeq F, Rizvi Q, Qureshi H, Ashfaq M . Changing pattern of antimicrobial susceptibility of organisms causing community acquired urinary tract infections. J Pak Med Assoc. 2000; 50(11):369-73. View

Sahm D, Thornsberry C, Mayfield D, Jones M, Karlowsky J . Multidrug-resistant urinary tract isolates of Escherichia coli: prevalence and patient demographics in the United States in 2000. Antimicrob Agents Chemother. 2001; 45(5):1402-6. PMC: 90480. DOI: 10.1128/AAC.45.5.1402-1406.2001. View

Drago L, De Vecchi E, Mombelli B, Nicola L, Valli M, Gismondo M . Activity of levofloxacin and ciprofloxacin against urinary pathogens. J Antimicrob Chemother. 2001; 48(1):37-45. DOI: 10.1093/jac/48.1.37. View

Mathai D, Jones R, Pfaller M . Epidemiology and frequency of resistance among pathogens causing urinary tract infections in 1,510 hospitalized patients: a report from the SENTRY Antimicrobial Surveillance Program (North America). Diagn Microbiol Infect Dis. 2001; 40(3):129-36. DOI: 10.1016/s0732-8893(01)00254-1. View

Navaneeth B, Belwadi S, Suganthi N . Urinary pathogens' resistance to common antibiotics: a retrospective analysis. Trop Doct. 2002; 32(1):20-2. DOI: 10.1177/004947550203200110. View

10.

Miller K, ONeill A, Chopra I . Response of Escherichia coli hypermutators to selection pressure with antimicrobial agents from different classes. J Antimicrob Chemother. 2002; 49(6):925-34. DOI: 10.1093/jac/dkf044. View

11.

Schaeffer A . The expanding role of fluoroquinolones. Am J Med. 2002; 113 Suppl 1A:45S-54S. DOI: 10.1016/s0002-9343(02)01059-8. View

12.

Astal Z, Sharif F . Antibiotic resistance of bacteria associated with community-acquired urinary tract infections in the southern area of the Gaza Strip. J Chemother. 2002; 14(3):259-64. DOI: 10.1179/joc.2002.14.3.259. View

13.

Kahlmeter G . An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO.SENS Project. J Antimicrob Chemother. 2002; 51(1):69-76. DOI: 10.1093/jac/dkg028. View

14.

Astal Z, Sharif F, Abdallah S, Fahd M . Multiresistant Escherichia coli isolated from women with community-acquired urinary tract infections in the Gaza Strip. J Chemother. 2003; 14(6):637-8. DOI: 10.1179/joc.2002.14.6.637. View

15.

Ronald A . The etiology of urinary tract infection: traditional and emerging pathogens. Dis Mon. 2003; 49(2):71-82. DOI: 10.1067/mda.2003.8. View

16.

Gupta K . Addressing antibiotic resistance. Dis Mon. 2003; 49(2):99-110. DOI: 10.1067/mda.2003.10. View

17.

Diekema D, BootsMiller B, Vaughn T, Woolson R, Yankey J, Ernst E . Antimicrobial resistance trends and outbreak frequency in United States hospitals. Clin Infect Dis. 2003; 38(1):78-85. DOI: 10.1086/380457. View

18.

Tolun V, Kucukbasmaci O, Torumkuney-Akbulut D, Catal C, Ang-Kucuker M, Ang O . Relationship between ciprofloxacin resistance and extended-spectrum beta-lactamase production in Escherichia coli and Klebsiella pneumoniae strains. Clin Microbiol Infect. 2004; 10(1):72-5. DOI: 10.1111/j.1469-0691.2004.00723.x. View

19.

Perfetto E, Keating K, Merchant S, Nichols B . Acute uncomplicated UTI and E. coli resistance: implications for first-line empirical antibiotic therapy. J Manag Care Pharm. 2004; 10(1):17-25. PMC: 10437401. DOI: 10.18553/jmcp.2004.10.1.17. View

20.

Shao H, Wang W, Zhang X, Li Z . [Distribution and resistance trends of pathogens from urinary tract infections and impact on management]. Zhonghua Nan Ke Xue. 2004; 9(9):690-2, 696. View